Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies

Title
Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies
Authors
Keywords
Benzothiazole, Anticancer, VEGFR-2, EGFR, QSAR, Molecular docking
Journal
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Volume 58, Issue -, Pages 128529
Publisher
Elsevier BV
Online
2022-01-07
DOI
10.1016/j.bmcl.2022.128529

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now